Larvol Delta - AB3028-a-Programmable-Circuit-T-Cell-Therapy-in-Patients-With-Castration-Resistant-Prostate-Cancer-CRPC

AB-3028 - ArsenalBio

http://clinicaltrials.gov/ct2/show/NCT07285694

Dec 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next